Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published-Ahead-of-Print October 18, 2006, DOI:10.2164/jandrol.106.000968
Journal of Andrology, Vol. 28, No. 2, March/April 2007
Copyright © American Society of Andrology
DOI: 10.2164/jandrol.106.000968

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/2/282    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benitez, D. A.
Right arrow Articles by Castellón, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benitez, D. A.
Right arrow Articles by Castellón, E. A.

Mechanisms Involved in Resveratrol-Induced Apoptosis and Cell Cycle Arrest in Prostate Cancer–Derived Cell Lines

DIXAN A. BENITEZ*, EULALIA POZO-GUISADO{dagger}, ALBERTO ALVAREZ-BARRIENTOS{ddagger}, PEDRO M. FERNANDEZ-SALGUERO{dagger} AND ENRIQUE A. CASTELLÓN*

From the * Laboratorio de Andrología Celular y Molecular, Programa de Fisiología y Biofísica, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile; the {dagger} Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias, Universidad de Extremadura, Badajoz, Spain; and the {ddagger} Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.

Correspondence to: Dr Enrique A Castellón, Laboratory of Cell and Molecular Andrology, Physiology and Biophysics Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Independencia 1027, PO Box 70005, Santiago-7, Chile (e-mail: ecastell{at}med.uchile.cl).


Resveratrol is a polyphenol found at high concentrations in grapes and red wine with reported anticarcinogenic effects. We studied the molecular mechanism of resveratrol-induced apoptosis and proliferation arrest in prostate derived cells PZ-HPV-7 (nontumorigenic line), LNCaP (androgen-sensitive cancer line), and PC-3 (androgen-insensitive cancer line). Apoptosis and cell cycle distribution were evaluated by flow cytometry and proliferation by MTT assay and direct cell counting. Caspases, bax, bcl-2, cyclins, Cdks, p53, p21, and p27 were measured by Western blot and kinase activities of cyclin/Cdk complexes by immunoprecipitation followed by kinase assays with appropriate substrates. Resveratrol induced a decrease in proliferation rates and an increase in apoptosis in cancer cell lines in a dose- and time-dependent manner. These effects were coincident with cell accumulation at the G0/G1 phase. In LNCaP and PC-3, the apoptosis induced by resveratrol was mediated by activation of caspases 9 and 3 and a change in the ratio of bax/bcl-2. Expressions of cyclin D1, E, and Cdk4 as well as cyclin D1/Cdk4 kinase activity were reduced by resveratrol only in LNCaP cells. In contrast, cyclin B and Cdk1 expression and cyclin B/Cdk1 kinase activity were decreased in both cell lines in the presence of resveratrol. However, modulator proteins p53, p21, and p27 were increased by resveratrol only in LNCaP cells. These effects probably result in the observed proliferation arrest and disruption of cell cycle control. In addition, the specific differences found between LNCaP and PC-3 suggest that resveratrol acts through different mechanisms upon the androgen or estrogen receptor cell status.

     Key words: Cyclins/Cdk complexes, androgen sensitivity, caspases, p53, p21




This article has been cited by other articles:


Home page
CarcinogenesisHome page
T.-c. Hsieh, C.-J. Yang, C.-Y. Lin, Y.-S. Lee, and J. M. Wu
Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells
Carcinogenesis, February 7, 2012; (2012) bgs016v2.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
L. KAI and A. S. LEVENSON
Combination of Resveratrol and Antiandrogen Flutamide Has Synergistic Effect on Androgen Receptor Inhibition in Prostate Cancer Cells
Anticancer Res, October 1, 2011; 31(10): 3323 - 3330.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
E. J. Calabrese, M. P. Mattson, and V. Calabrese
Resveratrol commonly displays hormesis: Occurrence and biomedical significance
Human and Experimental Toxicology, December 1, 2010; 29(12): 980 - 1015.
[Abstract] [PDF]


Home page
FASEB J.Home page
L. Brizuela, A. Dayon, N. Doumerc, I. Ader, M. Golzio, J.-C. Izard, Y. Hara, B. Malavaud, and O. Cuvillier
The sphingosine kinase-1 survival pathway is a molecular target for the tumor-suppressive tea and wine polyphenols in prostate cancer
FASEB J, October 1, 2010; 24(10): 3882 - 3894.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
H. Francis, G. Alpini, and S. DeMorrow
Recent advances in the regulation of cholangiocarcinoma growth
Am J Physiol Gastrointest Liver Physiol, July 1, 2010; 299(1): G1 - G9.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
D. H. Wong, J. A. Villanueva, A. B. Cress, and A. J. Duleba
Effects of resveratrol on proliferation and apoptosis in rat ovarian theca-interstitial cells
Mol. Hum. Reprod., April 1, 2010; 16(4): 251 - 259.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
N. Khan, V. M. Adhami, and H. Mukhtar
Apoptosis by dietary agents for prevention and treatment of prostate cancer
Endocr. Relat. Cancer, January 29, 2010; 17(1): R39 - R52.
[Abstract] [Full Text] [PDF]


Home page
Cancer Genomics ProteomicsHome page
H. Y. CHOI, S. A. CHONG, and M. J. NAM
Resveratrol Induces Apoptosis in Human SK-HEP-1 Hepatic Cancer Cells
Cancer Genomics Proteomics, September 1, 2009; 6(5): 263 - 268.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society of Andrology.